Back to video list Back to Home Eptinezumab – an efficacious, fast and sustained anti-CGRP monoclonal antibody therapy for preventive migraine treatment You may also like Depression Congress highlights Article ‘Smart’ prescribing of antidepressant medications? Migraine Article Attributing a causal role to migraine “triggers”: is greater caution needed? Article Balance vs burnout during COVID-19 Depression Article Functional impact of depression